These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27158692)

  • 1. Immunization update: This year's changes.
    Campos-Outcalt D
    J Fam Pract; 2016 Mar; 65(3):198-200. PubMed ID: 27158692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Advisory Committee on Immunization Practices
    MMWR Recomm Rep; 2000 Oct; 49(RR-9):1-35. PubMed ID: 11055835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014.
    Jayasinghe S; Menzies R; Chiu C; Toms C; Blyth CC; Krause V; McIntyre P
    Clin Infect Dis; 2017 Jan; 64(2):175-183. PubMed ID: 27986682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of pneumococcal conjugate vaccine on the prevention of invasive pneumococcal diseases.
    Bricks LF; Berezin E
    J Pediatr (Rio J); 2006 Jul; 82(3 Suppl):S67-74. PubMed ID: 16721440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pneumococcal conjugate vaccine update.
    Campos-Outcalt D
    J Fam Pract; 2019 Dec; 68(10):564-566. PubMed ID: 31860700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Nuorti JP; Whitney CG;
    MMWR Recomm Rep; 2010 Dec; 59(RR-11):1-18. PubMed ID: 21150868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumococcal conjugate vaccine is efficacious against invasive disease with fewer doses than currently recommended.
    Nohynek H
    Euro Surveill; 2006 Nov; 11(11):E061116.4. PubMed ID: 17213554
    [No Abstract]   [Full Text] [Related]  

  • 8. Pneumococcal conjugate vaccine for young children.
    Zimmerman RK
    Am Fam Physician; 2001 May; 63(10):1991-8. PubMed ID: 11388715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From the Centers for Disease Control and Prevention. Recommended childhood immunization schedule--United States, 2001.
    JAMA; 2001 Feb; 285(7):875-6. PubMed ID: 11236797
    [No Abstract]   [Full Text] [Related]  

  • 10. Vaccine policy decisions: tension between science, cost-effectiveness and consensus?
    Zimmerman RK; Jackson RE
    Am Fam Physician; 2001 May; 63(10):1919, 1923. PubMed ID: 11388708
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative safety evaluation of 7-valent and 13-valent pneumococcal vaccines in routine paediatric vaccinations in four Italian regions, 2009 to 2011.
    Trotta F; Rizzo C; Santuccio C; Bella A;
    Euro Surveill; 2015 Feb; 20(7):21-8. PubMed ID: 25719964
    [No Abstract]   [Full Text] [Related]  

  • 12. Pneumococcal polysaccharide-protein CRM197 conjugate vaccines, 7- or 9-valent, in the 2 + 1 schedule.
    Fritzell B; Fletcher MA
    Expert Rev Vaccines; 2011 Mar; 10(3):263-90. PubMed ID: 21434795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What are the latest recommendations for pneumococcal vaccines?
    Fabel PH; Horton EC; Shealy K
    JAAPA; 2016 Apr; 29(4):13-4. PubMed ID: 27023652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of infant immunization programs with pneumococcal conjugate vaccine in Europe.
    Rose M; Zielen S
    Expert Rev Vaccines; 2009 Oct; 8(10):1351-64. PubMed ID: 19803758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compared effectiveness of the 7-valent pneumococcal conjugate vaccine in children with the 13-valent vaccine in adults.
    Gaillat J
    Med Mal Infect; 2013 Jun; 43(6):215-21. PubMed ID: 23769155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Childhood immunisation (1): planned changes to the routine schedule.
    Diggle L
    Community Pract; 2006 Jul; 79(7):231-2. PubMed ID: 16878524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatricians' adherence to pneumococcal conjugate vaccine shortage recommendations in 2 national shortages.
    Fairbrother G; Broder K; Staat MA; Schwartz B; Heubi C; Hiratzka S; Walker FJ; Morrow AL
    Pediatrics; 2007 Aug; 120(2):e401-9. PubMed ID: 17646354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACIP extends delay in pneumococcal immunization of healthy children.
    Am J Health Syst Pharm; 2002 Feb; 59(3):228. PubMed ID: 11862630
    [No Abstract]   [Full Text] [Related]  

  • 19. Intervals Between PCV13 and PPSV23 Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Kobayashi M; Bennett NM; Gierke R; Almendares O; Moore MR; Whitney CG; Pilishvili T
    MMWR Morb Mortal Wkly Rep; 2015 Sep; 64(34):944-7. PubMed ID: 26334788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pneumococcal conjugate vaccination in children with recurrent acute otitis media: a therapeutic alternative?
    van Kempen MJ; Vermeiren JS; Vaneechoutte M; Claeys G; Veenhoven RH; Rijkers GT; Sanders EA; Dhooge IJ
    Int J Pediatr Otorhinolaryngol; 2006 Feb; 70(2):275-85. PubMed ID: 16140397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.